Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D001772:Blood Cell Count; D001779:Blood Coagulation Factors / Q000032:analysis; D002908:Chronic Disease; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000175:diagnosis*; D005165:Factor V / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis / Q000378:metabolism*; D005342:Fibrinolysis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007122:Immunoelectrophoresis; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D010953:Plasma Volume; D010958:Plasminogen / Q000032:analysis; D012636:Secretory Rate; D012712:Serum Globulins / Q000032:analysis; D013916:Thrombelastography; D014556:Urine / Q000032:analysis
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D007457:Iodine Radioisotopes; D012712:Serum Globulins; D005165:Factor V; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin